Immune signature-based risk stratification and prediction of immune checkpoint inhibitor’s efficacy for lung adenocarcinoma

BACKGROUND: Lung adenocarcinoma (LUAD) is a common pulmonary malignant disease with a poor prognosis. There were limited studies investigating the influences of the tumor immune microenvironment on LUAD patients’ survival and response to immune checkpoint inhibitors (ICIs). METHODS: Based on TCGA-LU...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Immunol Immunother
Main Authors: Yi, Ming, Li, Anping, Zhou, Linghui, Chu, Qian, Luo, Suxia, Wu, Kongming
Format: Artigo
Language:Inglês
Published: Springer Berlin Heidelberg 2021
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8139885/
https://ncbi.nlm.nih.gov/pubmed/33386920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-020-02817-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items